Our endeavours to strategically upgrade our infrastructure and manufacturing facilities have served us well. With the norms of Pharmaceutical manufacturing undergoing significant positive changes, keeping pace with the infrastructure requirement is challenging.
We have constantly monitored the changing environment and invested in keeping pace with the changing times. These investments have not been limited to plant and equipment, but extended to systems upgrades, skill development and know how building across the organisation.
Today, we possess amongst the best systems, processes and production facilities. We will continue to invest in keeping ahead of the changes that our industry would see in the coming years.
We have a modern Tabletting unit at Peenya, Bangalore. It had been set up with world-class, sophisticated & automatic manufacturing equipments and has received WHO GMP approval. This facility has a capacity to produce 50 lakh tablets per shift in a range of sugar coated, film coated and enteric coated versions.
This plant was audited by various MNC Pharmaceuticals and was approved by them to manufacture products under Loan licence basis. Combiflam (Aventis) was one of the important brands that was manufactured from 1997 to 2007 under this arrangement.
With our recent investment in our plant of over 8 crores, the plant is ready for meeting any regulatory audits. The plan includes having MCC level approval by end of this year.
We have a well-equipped R&D Department which is recognized by the Ministry of Science and Technology. Rigorously developed over the years, the R & D Department is the think-tank, which provides us not just the cutting edge of technology but keeps it a step ahead of the rest.
The R & D team is engaged in the development of new formulations in keeping with the latest advances in medical and pharmaceutical sciences. This apart, in its efforts to enhance benefits to our customers, the R & D team continuously strives towards innovating manufacturing procedures. Over the years our laboratory has developed a wide range of Pharmaceutical and Nutraceutical products in various therapeutic groups.
Our quality control policies ensure that the products manufactured are of the highest quality, safe and effective. Our products also comply with cGMP requirements. We have been awarded the prestigious “QUALITY EXCELLENCE AWARD” by IDMA in the years 1997 and 2004, in view of good quality systems and their implementation.
We have statistical and rigid sampling and approval procedures for the various inward materials, intermediates and finished products at every stage. Our product quality is established through a well defined stability plan in line with ICH guidelines. The Quality Control Department ensures that no product bearing the Anglo-French Drugs & Industries Ltd. insignia gets off the production line without successfully undergoing the most stringent tests.
Self inspection & self audit etc. are some of the tools by which we ensure proper adherence of defined procedures. Continuous training on cGMP and other aspects, both by in-house as well as by external agencies, keep the staff updated with their knowledge on current requirements.
In-built quality system provides:
» The confidence that the customer is well protected
» Evidence that ethical, legal and regulatory obligations are fulfilled
» Protects the Company’s reputation and maintains “customer confidence”
The Quality Control Unit aggressively monitors not only the finished products but also every procedure involved in making and marketing them. The Quality Control Department with its discerning eye has earned for the company, the coveted WHO GMP approval. With the tradition of excellence in manufacturing of oral formulations & parenterals, we march towards perfection. We strongly believe that the key factor for success is QUALITY and we are committed to the same.
In the competitive Indian pharmaceutical market, we have adopted an aggressive marketing approach which we seek to further strengthen. The vitality of Anglo-French Drugs & Industries Ltd. is derived from the dedicated and committed Marketing team spread over the entire Indian terrain, which comprises about 400+ strong field force, 23 C & F Depots and 1500+ Distributors. Our marketing capabilities are further strengthened with the presence of in-house studio to meet the day to day requirements in design and development of packaging & print promotional material
In addition to marketing our own formulations, we are presently looking out for strategic alliances with international companies for marketing their brands. Our vast experience in the Indian Pharmaceutical market, make us ideally suited vehicle for MNC firms wishing to enter and tap the vast market potential.
In our bid to be among the top 50 pharmaceutical companies in India, we have embarked on a strategy of launching new as well as well-established molecules. Our marketing thrust aims at providing customers with a wide range of latest quality products in therapeutic areas of vitamins, nutrition, sleep inducers and anti-epileptics. We aim at becoming a leader and an innovator in these areas.
Our efficient distribution network boasts of over 1500 Preferred Distributors located across the country. They are serviced by 23 Clearing and Forwarding agents located at major distribution centres in India.
The entire operations are streamlined with the recent introduction of SAP based ERP system. Inventory position is monitored on a day to day basis and actions to service the market taken from our base distribution point at Bangalore.
Achieving highest level of customer satisfaction thru efficient servicing of the orders is the number one priority at our distribution network.
Our efficient distribution network boasts of over 1500 Preferred Distributors located across the country. They are serviced by 23 Clearing and Forwarding agents located at major distribution centres in India.